Ссылки

1. EFCNI, Manzoni P, Tissieres P et al., European Standards of Care for Newborn Health: Prevention of necrotising enterocolitis (NEC). 2018.

2. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010 May;125(5):921—30. doi: 10.1542/peds. 2009—1301. Epub 2010 Apr 19.

3. Agostoni C, Buonocore G, Carnielli VP, et al: Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010;50:85—91. doi: 10.1097/MPG.0b013e3181adaee0.

4. World Gastroenterology Organisation Global Guidelines. Probiotics and prebiotics, October 2011.

5. Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):203—9. doi: 10.1097/MPG.0b013e3181dc0d93.

6. Holscher H.D., Czerkies L.A., Cekola P..et al. Bifidobacterium lactis BB-12® enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. JPEN J.Parenter. Enteral. Nutr. 2012;36:106S-117S. doi: 10.1177/0148607111430817.

7. Bifidobacterium (BB-12®), information from CHR Hansen, available https://www.chr-hansen.com/ru

8. Jungersen, M.; Wind, A.; Johansen, E.; Christensen, J.E.; Stuer-Lauridsen, B.; Eskesen, D. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms 2014, 2, 92—110. doi:10.3390/microorganisms2020092.

9. Health and Nutrition Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. FAO/WHO; Geneva, Switzerland: 2001.

10. Хавкин А.И. Нарушения микроэкологии кишечника. Принципы коррекции. Методические рекомендации, 2004 г.

11. A O'Callaghan et.al. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front.Microbiol.7:925, 2016. doi: 10.3389/fmicb.2016.00925

12. Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016 May;150(6):1257—61. doi: 10.1053/j.gastro.2016.03.035.

13. O'Mahony SM, Clarke G, Dinan TG, Cryan JF. Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle? Neuroscience. 2017;7;342:37—54.

14. Wang S. et.al. Targeting the gut microbiota to influence brain development and function in early life. Neuroscience & Biobehavioral Reviews, Volume 95, December 2018, Pages 191—201. doi: 10.1016/j.neubiorev.2018.09.002. Epub 2018 Sep 6.

15. Mayer E.A. et. al. Gut Microbes and the Brain: Paradigm Shift in Neuroscience. J Neurosci. 2014 Nov 12; 34(46): 15490—15496. doi: 10.1523/JNEUROSCI.3299—14.2014

16. Indrio F. et.al. Epigenetic Matters: The Link between Early Nutrition, Microbiome, and Long-term Health Development. Front. Pediatr., 22 August 2017. doi: 10.3389/fped.2017.00178. eCollection 2017.

17. Juan Miguel Rodri’guez et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microbial Ecology in Health & Disease (26) 2015. doi: 10.3402/mehd.v26.26050.

18. Langdon et al. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Medicine, 8:39, 2016. DOI 10.1186/s13073-016-0294-z.

19. Esaiassen E., Hjerde E. et.al. Effects of Probiotic Supplementation on the Gut Microbiota and Antibiotic Resistome Development in Preterm Infants. Front Pediatr. 2018; 6: 347. doi: 10.3389/fped.2018.00347.

20. Vos WM, Engstrand L. et.al. Human Microbiota in Health and Disease. SelfCare 2012;3(S1):1—68.

21. Ушкалова Е.А. «Живое» лекарство: Линекс. «ВРАЧ» 2007, специальный выпуск, с. 31—35.

22. Hill C., Guarner F. et.al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews. Gastroenterology & Hepatology. — 2014. — 11 (8): 506—14. doi: 10.1038/nrgastro.2014.66.

23. Probiotics database, available https://www.optibacprobiotics.co.uk/professionals/probiotics-database

24. Ардатская М. Д. Пробиотики, пребиотики и метабиотики в коррекции микроэкологических нарушений кишечника. Медицинский совет №13, 2015 г.

25. Бабаян М.Л. Возможные варианты профилактики антибиотикоассоциированных диарей у детей. Consilium Medicum. Педиатрия (Прил.). 1, 2017.

26. Xinias I., Analitis A. et.al. Innovative Dietary Intervention Answers to Baby Colic. Pediatr Gastroenterol Hepatol Nutr 2017 June 20(2):100—106. doi: 10.5223/pghn.2017.20.2.100.

27. Moayyedi P, Ford AC et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59: 325—32. doi: 10.1136/gut.2008.167270.

28. Hoveyda N, Heneghan C. et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009;9:15. doi: 10.1186/1471-230X-9-15.

29. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol. 2015 Mar 14;21(10):3072—84. doi: 10.3748/wjg.v21.i10.3072.

30. Hyams J.S., Di Lorenzo C. et.al. Childhood Functional Gastrointestinal Disorders: Child/Adolescent. Gastroenterology 2006 April; 130(5): 1527—1537. doi:10.1053/j.gastro.2005.08.063.

31. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada, April 30 and May 1, 2002.

32. Bifidobacterium animalis subsp. lactis BB-12®, KEGG pathway maps avaliable: https://www.kegg.jp/kegg-bin/show_organism?menu_type=pathway_maps&org=bbb

33. FDA. GRAS Notice (GRN) No. 856 https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory

34. Scientific Opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA, 2016. doi: 10.2903/j.efsa.2017.4664.

35. Berezhniy VV, Bondarets YuI. (2019). The Role of Prebiotics in Ensuring Health of Children: Literature Review and Own Research. Modern Pediatrics.Ukraine. 6(102): 9098. doi 10.15574/SP.2019.102.90.

36. Захарова И.Н., Дмитриева Ю.А. Штамм-специфические свойства Bifidobacterium animalis subsp. lactis (ВВ-12®). Эффективная фармакотрепия, 14, 2013.

37. Ушкалова Е.А., Зырянов С.К. Место препаратов, влияющих на микробиоту кишечника, в современной медицине. Педиатрия (Прил. к журн. Consilium Medicum). 2017; 2: 37–42.

38. Taipale T., Pienihakkinen K.et.al. Bifidobacterium animalis subsp. lactis BB-12® in reducing the risk of infections in infancy. Br. J. Nutr. 2011;105:409—416. doi: 10.1017/S0007114510003685.

39. Rautava S., Salminen S., et.al. Specific probiotics in reducing the risk of acute infections in infancy-A randomised, double-blind, placebo-controlled study. Br. J. Nutr. 2009;101:1722—1726. doi: 10.1017/S0007114508116282.

40. Rizzardini G., Eskesen D. et.al. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431 in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition (2012), 107, 876–884. doi:10.1017/S000711451100420X.

41. Guarino A. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014 //Journal of pediatric gastroenterology and nutrition. — 2014. — Т. 59. — №. 1. — С. 132—152.

42. Стандарти медицинської допомоги новонародженим в Польщі. Рекомендації Польської Спільноти неонатологів проф., др. габ. мед. наук Марія Катажина Боршевська—Корнацька

43. Інструкція для медичного застосування Лінекс Форте® Р.П. UA/14763/01/01